An antibody drug decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have severe asthma, are prone to asthma attacks and live in low-income urban neighborhoods, a federally funded study led by UW-Madison researchers found.
Medications like mepolizumab have “revolutionized” treatment for adults with severe asthma, but data in children and diverse populations had been limited, said Dr. Daniel Jackson, a UW School of Medicine and Public Health professor of pediatrics who led the study, funded by the National Institutes of Health.